GlaxoSmithKline

Q3 results 2014

22 Oct 2014

Pharma group announces Q3 2014 results including a restructuring of the business and a possible partial IPO of ViiV Healthcare. Interview with Sir Andrew Witty, CEO, and Simon Dingemans, CFO.